Mlq Ai
Published November 16, 2026 · Updated November 17, 2026
Helus Pharma's psychedelic depression drug meets its Phase 3 goal but faces safety questions
Helus Pharma said its psychedelic drug HLP003 met the main goal of the Phase 3 APPROACH study in adults with major depression whose symptoms.
Surfaced by 2 Google Alerts
- Psychedelics
- Psychedelic press release